Kunming Longjin Pharmaceutical Co Ltd (002750) — Capital Reinvestment Ratio
Kunming Longjin Pharmaceutical Co Ltd (002750) has a Capital Reinvestment Ratio of 6.23x as of December 2022, meaning it reinvests 6% of its operating cash flow (CN¥867.54K) in capital expenditures (CN¥5.41 Million). See debt-free asset ratio of Kunming Longjin Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kunming Longjin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2019)
This chart tracks Kunming Longjin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check Kunming Longjin Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kunming Longjin Pharmaceutical Co Ltd (2011–2019)
Year-by-year Capital Reinvestment Ratio for Kunming Longjin Pharmaceutical Co Ltd from 2011 to 2019. For live market cap and broader valuation context, see Kunming Longjin Pharmaceutical Co Ltd (002750) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 1.75x | CN¥4.04 Million | CN¥7.07 Million | ▲ +257.1% |
| 2018 | 0.49x | CN¥31.70 Million | CN¥15.53 Million | ▲ +62.2% |
| 2017 | 0.30x | CN¥58.06 Million | CN¥17.54 Million | ▲ +33.7% |
| 2016 | 0.23x | CN¥104.24 Million | CN¥23.56 Million | ▼ -33.7% |
| 2015 | 0.34x | CN¥70.19 Million | CN¥23.93 Million | ▲ +29.5% |
| 2014 | 0.26x | CN¥70.16 Million | CN¥18.47 Million | ▼ -52.9% |
| 2013 | 0.56x | CN¥106.46 Million | CN¥59.57 Million | ▼ -31.2% |
| 2012 | 0.81x | CN¥91.16 Million | CN¥74.14 Million | ▼ -33.5% |
| 2011 | 1.22x | CN¥75.90 Million | CN¥92.79 Million | — |